FTH
Faeth Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$40.05
+2.69%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.98x
- Price / sales
- -213.34x
- Price / cash flow
- -30.57x
Enterprise value
- Enterprise value
- $849.1M
- EV / sales
- -175.03x
- EV / EBITDA
- -4.35x
- EV / EBIT
- -4.27x
- Market cap
- $1.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026